CORT – corcept therapeutics incorporated (US:NASDAQ)
Stock Stats
News
3 High Insider Ownership US Growth Companies With Earnings Growth Up To 70% [Yahoo! Finance]
Pipeline Moves: Phase III completion for Corcept's relaorilant [Yahoo! Finance]
Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement
Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at HC Wainwright from $38.00 to $40.00. They now have a "buy" rating on the stock.
Form 4 CORCEPT THERAPEUTICS For: May 13 Filed by: Maduck Sean
Form 4 CORCEPT THERAPEUTICS For: May 09 Filed by: Lyon Joseph Douglas
Form 144 CORCEPT THERAPEUTICS Filed by: Maduck Sean
Form 144 CORCEPT THERAPEUTICS Filed by: Lyon Joseph Douglas
Form 4 CORCEPT THERAPEUTICS For: May 02 Filed by: Lyon Joseph Douglas
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.